In this portion of our Pharma Executive Video Interviews, Bryce Shalamel, VP of AI Products and Platforms at Moderna, talks about how Moderna is leveraging its collaboration with OpenAI to accelerate the development and launch of its upcoming mRNA medicines.
Accelerating the development and launch of future mRNA drugs with OpenAI
Leave a Comment
